Search results
Showing results for
James Fullerton appointed as John Climax Professor of Clinical Therapeutics
1 May 2026
Professor Fullerton will take a leading role in clinical pharmacology and experimental medicine research in Oxford to help bridge the gap between discoveries in the laboratory and the development of new drug treatments.
First myeloma patient joins NDORMS trial of radioactive bone scan
11 September 2025
In a world first researchers at NDORMS are testing a new technology that could enable clinicians to better diagnose and treat myeloma.
NDORMS researchers deliver pioneering treatment for rare genetic condition
15 May 2025
A team at NDORMS, University of Oxford has successfully administered a pioneering treatment to a patient with XIAP deficiency, a rare genetic disorder.